A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.
Hosted on MSN5d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial"The trial shows that aspirin is well tolerated in this patient group but does not demonstrate a significant reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback